A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis. (2019)

First Author: Kitas GD
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/art.40892

PubMed Identifier: 30983166

Publication URI: http://europepmc.org/abstract/MED/30983166

Type: Journal Article/Review

Volume: 71

Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)

Issue: 9

ISSN: 2326-5191